The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,950.00
Bid: 2,948.00
Ask: 2,952.00
Change: -22.00 (-0.74%)
Spread: 4.00 (0.136%)
Open: 2,968.00
High: 2,968.00
Low: 2,942.00
Prev. Close: 2,972.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

30 Jun 2022 07:00

RNS Number : 7013Q
Bunzl PLC
30 June 2022
 

30 June 2022

 

BUNZL PRE-CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2022.

 

The Group is expected to deliver very strong growth over the period, reflecting the resilience and strength of the Bunzl business model. Group revenue in the first half is expected to increase year-on-year by approximately 16% at actual exchange rates and by 12-13% at constant exchange rates1, with inflation continuing to drive underlying revenue growth and the impact of acquisitions further supplementing growth. Group adjusted operating margin for the first half is expected to be slightly higher than historical annual levels.

 

Across our business areas inflation remains the key driver of performance. Very strong revenue growth has been maintained in North America over the period and negotiations with our largest customer are constructive and ongoing. Continental Europe similarly maintained strong momentum, whilst the UK & Ireland's operating margin continues to see year-on-year improvement alongside very strong base business recovery. Rest of the World's revenue growth has been moderate, with very strong growth in Asia Pacific partially offset by the expected decline in Covid-19 related sales in Latin America.

 

The Group is upgrading its guidance for the year on the basis of very strong revenue growth to date and announced acquisitions. At constant exchange rates the Group now expects very good revenue growth in 2022, driven by good organic revenue growth and the positive contribution of acquisitions announced in the last 12 months. Growth of the base business is expected to be only partially offset by the further normalisation of sales of Covid-19 related products, albeit these are expected to remain ahead of 2019 levels. We continue to expect Group operating margin in 2022 to be slightly higher than historical levels.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Bunzl has delivered another period of strong growth. We continue to demonstrate the strength of our business model, supported by the depth and resilience of our supply chains and the agility of our people who have responded to the inflationary environment so successfully. Our acquisition momentum remains strong, with our active pipeline supported by a strong balance sheet."

 

 

Note:

1. The number of trading days will not have an impact on growth over the period. 

 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDLUSDDGDC
Date   Source Headline
15th Jul 20164:32 pmRNSDirector/PDMR Shareholding
5th Jul 20161:20 pmRNSDirector/PDMR Shareholding
4th Jul 201610:37 amRNSHolding(s) in Company
1st Jul 20161:13 pmRNSTotal Voting Rights
1st Jul 201612:16 pmRNSHolding(s) in Company
30th Jun 20163:48 pmRNSDirector/PDMR Shareholding
29th Jun 20164:36 pmRNSDirector/PDMR Shareholding
29th Jun 201610:12 amRNSHolding(s) in Company
29th Jun 20167:00 amRNSTrading Statement
27th Jun 20169:42 amRNSHolding(s) in Company
1st Jun 20162:00 pmRNSTotal Voting Rights
23rd May 20164:54 pmRNSDirector/PDMR Shareholding
11th May 20161:54 pmRNSAdditional Listing
5th May 20167:00 amRNSAcquisition
3rd May 20164:35 pmRNSTotal Voting Rights
3rd May 201610:50 amRNSBlock listing Interim Review
20th Apr 20162:40 pmRNSResult of AGM
20th Apr 20167:00 amRNSTrading Statement
14th Apr 20164:59 pmRNSDirector/PDMR Shareholding
11th Apr 20164:32 pmRNSDirector/PDMR Shareholding
6th Apr 201612:05 pmRNSDirector/PDMR Shareholding
6th Apr 201611:32 amRNSDirector/PDMR Shareholding
1st Apr 20161:48 pmRNSTotal Voting Rights
31st Mar 20164:39 pmRNSDirector/PDMR Shareholding
31st Mar 201612:05 pmRNSDirector Declaration
29th Mar 20162:49 pmRNSDirector/PDMR Shareholding
23rd Mar 20164:50 pmRNSDirector/PDMR Shareholding
23rd Mar 201612:11 pmRNSAdditional Listing
17th Mar 20163:05 pmRNSAnnual Financial Report
15th Mar 20164:32 pmRNSDirector/PDMR Shareholding
14th Mar 20164:49 pmRNSDirector/PDMR Shareholding
11th Mar 20164:59 pmRNSDirector/PDMR Shareholding
4th Mar 20162:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20161:37 pmRNSDirector/PDMR Shareholding
2nd Mar 20164:51 pmRNSDirector/PDMR Shareholding
1st Mar 20164:58 pmRNSDirector/PDMR Shareholding
1st Mar 20164:57 pmRNSDirector/PDMR Shareholding
1st Mar 201612:39 pmRNSTotal Voting Rights
29th Feb 20161:09 pmRNSDividend Declaration
29th Feb 20167:00 amRNSFinal Results
29th Feb 20167:00 amRNSAcquisition
3rd Feb 20162:35 pmRNSDirector/PDMR Shareholding
1st Feb 201612:10 pmRNSTotal Voting Rights
18th Jan 201611:46 amRNSDirector Declaration
14th Jan 20167:00 amRNSDirectorate Change
13th Jan 20169:56 amRNSDirector/PDMR Shareholding
6th Jan 20164:03 pmRNSDirector/PDMR Shareholding
4th Jan 20161:51 pmRNSTotal Voting Rights
16th Dec 20157:00 amRNSTrading Statement
4th Dec 20159:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.